Ampio Pharmaceuticals, Inc. Announces Appointment of New Chief Financial Officer to be Effective April 4, 2011 PR Newswire GREENWOOD VILLAGE...
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM D OMB APPROVAL OMB Number: 3235-0076 Expires: June 30, 2012...
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant...
Table of Contents Filed pursuant to Rule 424(b)(3) File No. 333-171579 INFORMATION STATEMENT/PROSPECTUS...
Table of Contents As filed with the Securities and Exchange Commission on February 17, 2011...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark...
Table of Contents As filed with the Securities and Exchange Commission on January 13, 2011...
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 2 TO FORM 8-K ...
Table of Contents As filed with the Securities and Exchange Commission on January 6, 2011...
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 TO FORM 8-K ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.